Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.930
-0.000 (-0.02%)
At close: Apr 28, 2026, 4:00 PM EDT
0.948
+0.019 (1.99%)
After-hours: Apr 28, 2026, 7:21 PM EDT
Jasper Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 20.28 | 20.42 | 17.08 | 16.57 | 11.41 | |
| Research & Development | 61.3 | 55.82 | 51.79 | 34.63 | 25.42 | |
| Operating Expenses | 81.58 | 76.24 | 68.86 | 51.2 | 36.83 | |
| Operating Income | -81.58 | -76.24 | -68.86 | -51.2 | -36.83 | |
| Interest & Investment Income | 1.74 | 5.06 | 5.2 | 0.7 | - | |
| Other Non Operating Income (Expenses) | 6.34 | -0.09 | -0.82 | 7.09 | -3.08 | |
| EBT Excluding Unusual Items | -73.5 | -71.27 | -64.48 | -43.41 | -39.91 | |
| Merger & Restructuring Charges | -2.3 | - | - | - | - | |
| Other Unusual Items | - | - | 0.02 | 5.73 | 9.28 | |
| Pretax Income | -75.8 | -71.27 | -64.47 | -37.69 | -30.64 | |
| Net Income | -75.8 | -71.27 | -64.47 | -37.69 | -30.64 | |
| Net Income to Common | -75.8 | -71.27 | -64.47 | -37.69 | -30.64 | |
| Shares Outstanding (Basic) | 19 | 15 | 10 | 4 | 1 | |
| Shares Outstanding (Diluted) | 19 | 15 | 10 | 4 | 1 | |
| Shares Change (YoY) | 31.42% | 39.72% | 186.15% | 220.19% | 558.67% | |
| EPS (Basic) | -3.95 | -4.89 | -6.18 | -10.33 | -26.89 | |
| EPS (Diluted) | -3.95 | -4.89 | -6.18 | -10.33 | -26.89 | |
| Free Cash Flow | -77.17 | -63.15 | -52.33 | -46.43 | -36.11 | |
| Free Cash Flow Per Share | -4.03 | -4.33 | -5.01 | -12.73 | -31.69 | |
| EBITDA | -80.53 | -74.87 | -67.75 | -50.22 | -36.46 | |
| D&A For EBITDA | 1.06 | 1.37 | 1.11 | 0.98 | 0.38 | |
| EBIT | -81.58 | -76.24 | -68.86 | -51.2 | -36.83 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.